Definitions of fatal bleeding in clinical studies evaluating anticoagulant treatment for venous thromboembolism: A scoping review

• Published in: Journal of thrombosis and haemostasis 2023-06, Vol.21 (6), p.1553-1566
• Main Authors: Schenker, Carla, Marx, Caterina E., Kraaijpoel, Noémie, Le Gal, Grégoire, Siegal, Deborah M., Klok, Frederikus A., Aujesky, Drahomir, Tritschler, Tobias
• Format: Article
• Language: English
• Subjects: Anticoagulants - adverse effects; anticoagulation; bleeding; cause of death; Hemorrhage - chemically induced; Hemorrhage - drug therapy; Humans; Neoplasm Recurrence, Local - drug therapy; outcome assessment; Prospective Studies; venous thromboembolism; Venous Thromboembolism - diagnosis; Venous Thromboembolism - drug therapy
• ISSN: 1538-7836; 1538-7836
• DOI: 10.1016/j.jtha.2023.02.013

Fatal bleeding is a component of the primary safety outcome in most studies evaluating anticoagulation for venous thromboembolism (VTE), but a standardized definition for fatal bleeding is lacking. To summarize definitions of fatal bleeding and describe the range of case-fatality rates of major bleeding in VTE studies. MEDLINE, Embase, and CENTRAL databases were searched from January 2008 to July 2021 for prospective studies that enrolled patients with VTE and evaluated the efficacy/safety of anticoagulation for VTE treatment or included fatal or major bleeding as primary outcome. Two authors independently performed study selection and data extraction. The primary outcome was the definition of fatal bleeding. The secondary outcome was the case-fatality rate of major bleeding. Data were analyzed using descriptive statistics. Of 4911 records identified, we included 132 articles representing 89 distinct studies. Twenty-seven (20%) articles and 7 of 89 (8%) studies reported a definition of fatal bleeding. Overall, we identified 3 different types of definitions that were either on the basis of a specific time interval between bleeding and death, bleeding location (intracranial) or clinical presentation (hemodynamic deterioration), or mainly relied on the judgment of the adjudication committee to determine the cause of death. The case-fatality rate of major bleeding ranged from 0 to 60% (median, 9.1%; interquartile range, 2.8%-18%). Less than 10% of studies assessing anticoagulant treatment for VTE reported a definition for fatal bleeding. The lack of a (standardized) definition for fatal bleeding may lead to inaccurate estimates of the risk of fatal bleeding, particularly when compared across studies. •We aimed to summarize the definitions of fatal bleeding in venous thromboembolism (VTE) studies.•We conducted a scoping review of prospective studies assessing anticoagulation for VTE treatment.•Twenty percent of articles and 8% of studies reported a definition for fatal bleeding.•Case-fatality rates of major bleeding varied widely. A standardized definition of fatal bleeding is needed.